carvedilol and pyrogallol

carvedilol has been researched along with pyrogallol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Christopher, TA; Feuerstein, GZ; Lopez, BL; Ma, XL; Ruffolo, R; Yue, TL	1
Behnam-Motlagh, P; Grankvist, K; Henriksson, R; Jonsson, O; Persson, M	1

Other Studies

2 other study(ies) available for carvedilol and pyrogallol

Article	Year
Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction. Pharmacology, 1995, Volume: 51, Issue:3 Topics: Acetylcholine; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Endothelium, Vascular; Free Radicals; In Vitro Techniques; Male; Nitric Oxide; Penicillamine; Propanolamines; Pyrogallol; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Superoxides; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents	1995
Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity. Biochemical pharmacology, 1999, Dec-01, Volume: 58, Issue:11 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carbazoles; Carvedilol; Cell Division; Doxorubicin; Drug Synergism; Fluoresceins; Fluorescence; Free Radicals; Humans; Propanolamines; Pyrogallol; Tumor Cells, Cultured; Verapamil	1999

Article

Year

Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction.

Pharmacology, 1995, Volume: 51, Issue:3

Topics: Acetylcholine; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Endothelium, Vascular; Free Radicals; In Vitro Techniques; Male; Nitric Oxide; Penicillamine; Propanolamines; Pyrogallol; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Superoxides; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

1995

Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity.

Biochemical pharmacology, 1999, Dec-01, Volume: 58, Issue:11

Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carbazoles; Carvedilol; Cell Division; Doxorubicin; Drug Synergism; Fluoresceins; Fluorescence; Free Radicals; Humans; Propanolamines; Pyrogallol; Tumor Cells, Cultured; Verapamil

1999